Drug intelligence / Profile preview

sterylamine

Development stage: Unknown
Modality: Small Molecules
Administration: Ophthalmic, Topical, Injection, Inhalation

Overview

Sterylamine is a small molecule chemical compound primarily functioning as a surfactant and stabilizing agent in various drug delivery systems, including nanocarriers and liposomes, to enhance drug encapsulation and targeted delivery. It also acts as an adjuvant in vaccines, stimulating immune responses. Additionally, sterylamine exhibits direct biological activities, such as inhibiting ornithine decarboxylase (ODC) and thyrotropin-releasing hormone (TRH) binding.

Targets

ODC1 (Ornithine decarboxylase)TRHR (Thyrotropin-releasing hormone receptor)

Beyond the preview

Go deeper on sterylamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on sterylamine.

Explore the full profile